The Kaplan–Meier overall survival (OS) analysis from GEPIA2 database depicted that pancreatic cancer patients with high CASC19 expression exhibited significantly poorer survival than the PDAC patients with low expression of CASC19 (Fig. 1G). Here, CASC19 is linked to pancreatic neoplasm.